Re: "Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost effective?" by Sanders et al.
Järvinen
Teppo L N
TL
Kannus
Pekka
P
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005260:Female; D050723:Fractures, Bone / Q000191:economics / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy
D050071:Bone Density Conservation Agents